NOVAREX Co.,Ltd.

Research NOVAREX Co.,Ltd. (194700.KQ) on Bullrun: market cap KRW 176.13B, dividend yield 4.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 176.13B; dividend yield is 4.0%.

Peer valuation comparison

Latest dividend yield is 3.96% versus a Consumer Defensive sector median of 2.92% (35.6% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 176.13Bn/a4.0%400

Dividend history

Latest trailing dividend snapshot: annual dividend/share 400 KRW, yield 4.0%.

About NOVAREX Co.,Ltd.

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd.

Related stock research

Other Consumer Defensive stocks

Frequently asked questions

What is NOVAREX Co.,Ltd.'s market cap?

NOVAREX Co.,Ltd.'s market capitalization is KRW 176.13B.

Does NOVAREX Co.,Ltd. pay a dividend?

NOVAREX Co.,Ltd. has a dividend yield of 4.0%.

What does NOVAREX Co.,Ltd. do?

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Korea.